In summary, our study provides evidence that METTL3 depletion-mediated reductions in m6A modification affect endothelial barrier function in sepsis-induced ARDS, which ultimately increases endothelial permeability and aggravates the inflammatory response, thereby increasing sepsis-associated mortality. Here, METTL3 is linked to Sepsis.